| |
| |
|
| Insider
Information: |
Higgins John L |
| Relationship: |
Director |
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
2,806,928 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$49,292,582 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
2,806,928 |
|
|
| Total
Value |
$49,292,582 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
10
|
|
Stock
price went up :
|
0
|
5
|
| Stock
price went down : |
0
|
5
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -30.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ligand Pharmaceuticals Inc |
LGND |
Director |
2022-12-28 |
417,695 |
2007-02-01 |
0 |
Premium* |
|
|
Techne Corp |
TECH |
Director |
2023-10-26 |
36,608 |
2013-10-31 |
0 |
Premium* |
|
|
OmniAb, Inc |
OABI |
Director |
2024-01-30 |
2,352,625 |
2022-11-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
163 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LGND |
Ligand Pharmaceuticals In... |
CEO & President |
• – – |
2007-02-01 |
4 |
A |
$12.68 |
$1,902,000 |
D/D |
150,000 |
150,000 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
President & CEO |
• • – |
2008-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
28,000 |
257,000 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
President & CEO |
• • – |
2008-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
229,000 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
President & CEO |
• • – |
2009-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
24,000 |
356,000 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
President & CEO |
• • – |
2009-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
332,000 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
President & CEO |
• • – |
2009-12-31 |
4 |
A |
$1.84 |
$2,099 |
D/D |
1,138 |
333,138 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
President & CEO |
• • – |
2010-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
433,276 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
President & CEO |
• • – |
2010-06-30 |
4 |
A |
$1.24 |
$2,100 |
D/D |
1,692 |
440,968 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
President & CEO |
• • – |
2010-12-31 |
4 |
A |
$7.14 |
$2,099 |
D/D |
294 |
73,788 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
President & CEO |
• • – |
2011-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
88,494 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
President & CEO |
• • – |
2011-06-30 |
4 |
A |
$7.64 |
$2,116 |
D/D |
277 |
89,065 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
President & CEO |
• • – |
2011-12-30 |
4 |
A |
$10.09 |
$2,119 |
D/D |
210 |
89,275 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
President & CEO |
• • – |
2012-02-09 |
4/A |
A |
$0.00 |
$0 |
D/D |
6,000 |
95,275 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
President & CEO |
• • – |
2012-06-29 |
4 |
A |
$10.12 |
$12,654 |
D/D |
1,250 |
109,525 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
President & CEO |
• • – |
2013-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
8,000 |
120,025 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
President & CEO |
• • – |
2013-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
12,000 |
120,025 |
0 |
- |
|
| TECH |
Techne Corp |
Director |
– • – |
2013-10-31 |
4 |
A |
$0.00 |
$0 |
D/D |
1,000 |
1,000 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
President & CEO |
• • – |
2014-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
8,000 |
119,099 |
0 |
- |
|
| TECH |
Techne Corp |
Director |
– • – |
2014-10-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,000 |
2,000 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
President & CEO |
• • – |
2015-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
15,945 |
136,044 |
0 |
- |
|
| TECH |
Techne Corp |
|
– • – |
2015-10-29 |
4 |
A |
$0.00 |
$0 |
D/D |
1,059 |
3,059 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2016-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
11,611 |
132,989 |
0 |
- |
|
| TECH |
Techne Corp |
Director |
– • – |
2016-10-27 |
4 |
A |
$0.00 |
$0 |
D/D |
914 |
2,273 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2017-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
19,392 |
132,969 |
0 |
- |
|
| TECH |
Techne Corp |
|
– • – |
2017-10-26 |
4 |
A |
$0.00 |
$0 |
D/D |
739 |
3,012 |
0 |
- |
|
163 Records found
|
|
Page 1 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
